HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction von Rahtu-Korpela, Lea, Karsikas, Sara, Hörkkö, Sohvi, Blanco Sequeiros, Roberto, Lammentausta, Eveliina, Mäkelä, Kari A, Herzig, Karl-Heinz, Walkinshaw, Gail, Kivirikko, Kari I, Myllyharju, Johanna, Serpi, Raisa, Koivunen, Peppi

Volltext

Activation of Hypoxia Response in Endothelial Cells Contributes to Ischemic Cardioprotection von Kerkelä, Risto, Karsikas, Sara, Szabo, Zoltan, Serpi, Raisa, Magga, Johanna, Gao, Erhe, Alitalo, Kari, Anisimov, Andrey, Sormunen, Raija, Pietilä, Ilkka, Vainio, Laura, Koch, Walter J., Kivirikko, Kari I., Myllyharju, Johanna, Koivunen, Peppi

Volltext

INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 DIAbetes in autoantibody positive parti... von Kero, Jukka, Koskenniemi, Jaakko J., Karsikas, Sara, Pokka, Tytti, Lou, Olivia, Toppari, Jorma, Veijola, Riitta

Volltext

HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury von Karsikas, Sara, Myllymäki, Mikko, Heikkilä, Minna, Sormunen, Raija, Kivirikko, Kari I., Myllyharju, Johanna, Serpi, Raisa, Koivunen, Peppi

Volltext